E-LIB Suche - Ergebnisse für: Mould, J.F.

1

Childhood predictors of cardiovascular disease in adulthood..:

Ajala, O. ; Mold, F. ; Boughton, C...
Obesity Reviews. 18 (2017) 9 - p. 1061-1070 , 2017

Link: https://doi.org/10.1111/..

2

Quality improvement of physical health monitoring for peopl..:

Edwards, J. ; Mold, F. ; Knivett, D....
Journal of Intellectual Disability Research. 62 (2017) 3 - p. 199-216 , 2017

Link: https://doi.org/10.1111/..

3

GRAZING BEHAVIOUR OF DAIRY COWS AND BODY CONDITION SCORE AS..:

CASTELÁN-ORTEGA, O. A. ; MARTÍNEZ-GARCÍA, C. G. ; MOULD, F. L....
Experimental Agriculture. 54 (2016) 2 - p. 214-226 , 2016

Link: https://doi.org/10.1017/..

4

Cost-Utility Of Celecoxib Compared To Other Nsaids For The ..:

Leisewitz, T. ; Mould, J.F. ; Bryon, A...
Value in Health. 17 (2014) 3 - p. A47 , 2014

Link: https://doi.org/10.1016/..

5

Treatment Patterns and Health Resource Utilization Among At..:

Johnston, K. ; Osenenko, K.M. ; Donato, B.M.K....
Value in Health. 17 (2014) 7 - p. A504 , 2014

Link: https://doi.org/10.1016/..

6

Estimation of the Cost-Effectiveness of Apixaban in Non-Val..:

Giorgi, M.A. ; Caroli, C. ; Micone, P....
Value in Health. 16 (2013) 7 - p. A666 , 2013

Link: https://doi.org/10.1016/..

7

Costs and Consequences of Oral Anticoagulation in Atrial Fi..:

Rosselli, D. ; Rueda, J.D. ; García, Á.A....
Value in Health. 16 (2013) 7 - p. A702 , 2013

Link: https://doi.org/10.1016/..

8

Economic evaluation of apixaban for atrial fibrillation in ..:

Rosado-Buzzo, A. ; Garcia-Mollinedo, L. ; Luna-Casas, G....
Value in Health. 16 (2013) 3 - p. A286 , 2013

Link: https://doi.org/10.1016/..

9

Cost-Utility of Apixaban Compared to Warfarin for Stroke Pr..:

Rosselli, D. ; Rueda, J.D. ; García, Á.A....
Value in Health. 16 (2013) 7 - p. A706 , 2013

Link: https://doi.org/10.1016/..

10

Cost-Effectiveness And Cost-Utility Analysis Of Sunitinib V..:

Torres Toala, F.G. ; Albuja Riofrio, M.F. ; Mould, J.F..
Value in Health. 16 (2013) 3 - p. A139 , 2013

Link: https://doi.org/10.1016/..

11

PSS15 Economic Analysis of Etanercept as Continuous or Paus..:

Fernandes, R.A. ; Takemoto, M.L.S. ; Amaral, L.M....
Value in Health. 15 (2012) 4 - p. A252 , 2012

Link: https://doi.org/10.1016/..

12

PRS14 Cost-Effectiveness of Azithromycin and Clarithromycin..:

Fujii, R.K. ; Mould, J.F. ; Lanzara, G.D.A..
Value in Health. 15 (2012) 4 - p. A53-A54 , 2012

Link: https://doi.org/10.1016/..

13

PIH61 Burden of Disease in Patients with Menopause in Brazi..:

Mould, J.F. ; Fujii, R.K. ; Boulos, F.C..
Value in Health. 15 (2012) 4 - p. A202-A203 , 2012

Link: https://doi.org/10.1016/..

14

PSS14 Economic Analysis of Etanercept as Paused Therapy in ..:

Fernandes, R.A. ; Takemoto, M.L.S. ; Amaral, L.M....
Value in Health. 15 (2012) 4 - p. A252 , 2012

Link: https://doi.org/10.1016/..

15

PSY46 Burden of Disease in Patients With Diagnosed Psoriasi..:

Fujii, R.K. ; Mould, J.F. ; Tang, B....
Value in Health. 15 (2012) 4 - p. A107 , 2012

Link: https://doi.org/10.1016/..